Elevated VEGF expression is frequently observed in gastric cancer tissues and correlates with tumor invasiveness, clinical staging, and prognosis.101 Ramucirumab, a recombinant human monoclonal antibody targeting VEGFR2, has been extensively studied in various settings for advanced GC or GEJ adenocarcinoma. This evidence concerns the gene VEGFA and gastric cancer.